Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

Clinical trial NCT00143520 · COMPLETED

Trial details

NCT number: NCT00143520
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2004-12-01
Primary completion: 2005-12-01
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.